|
|
|
By Nathan Parker, principal consultant, Parker Biopharmaceutical Consulting | The COVID-era guidance is designed to help manufacturers make container closure system changes quickly when facing supply constraints. It may be useful when evaluating risks beyond the pandemic. |
|
|
|
In this segment, industry professionals discuss when teams should start thinking about automation in their operations and, more importantly, what key questions to ask when building a company’s automation framework. |
|
|
|
| Transforming CGT With A Synergistic Partnership | Article | Cencora | Understand the strategic advantages of a new collaboration and discover how two companies' unified vision promises to elevate CGT to new heights, one empowered patient at a time. |
|
|
| Access And Support For Cell And Gene Therapy | Article | Cardinal Health | Experienced patient support hubs play a pivotal role in navigating the entire treatment journey, significantly reducing the time between treatment determination and therapy initiation for CGT patients. |
|
|
| Evaluating A Novel Cyclic Olefin Polymer Container System For Storing AAV | Poster | By Rui Li, Samuel A. Molina, Katie Glen, Jon Harriman, Crystal Kraft, Vidya Murthy, Robert Thomas, and Alexander Lyness, West Pharmaceutical Services, Inc. | This study investigates the suitability of a container system composed of the novel COP CZ as an alternative for the ultra-cold storage of therapeutically relevant AAV viral vectors. |
|
|
|
| Reliable Osmolality Testing Of High-Concentration mAb Formulations | White Paper | By Kristeena Wright, Laura Chinn, Kendal Studd, Samantha Heidlebaugh, Cianna Cooper, Cameron Bardliving, and Nancy Perlmutter, Jefferson Institute for Bioprocessing (JIB) | Review an evaluation of the OsmoTECH XT (freezing point) and Vapro 5600 (vapor pressure) osmometers as a means of measuring concentrated protein formulations. |
|
|
| Upstream Optimization Paves The Way For Full Capsids In AAV6 | Poster | By James Fasano, Azam Hassaninasab, Daniel Kennedy, Theresa Dao, Jay Cai, Omar Matalka, Christine Beaudry, Miranda Williams, Lorenz Ponce, Arianna Spooner, Emily Sinclair, Bojiao Yin, and Mercedes Segura, ElevateBio | Because clinical applications for AAV are increasing rapidly, there is a high demand for further increasing yields as well as product quality, particularly for a higher percentage of full capsids in the final product. |
|
|
|
| Setting Expectations For Post-Thaw Segment QC Testing On A CBU | Poster | Comprehensive Cell Solutions, A Business Unit of NYBC Enterprises | Examine the post-thaw segment QC results for 2,249 consecutive segments cut at our institution, in order to create a benchmark of what is to be expected when interpreting segment testing. |
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
